Development of novel M1 antagonist scaffolds through the continued optimization of the MLPCN probe ML012.
Melancon BJ, Utley TJ, Sevel C, Mattmann ME, Cheung YY, Bridges TM, Morrison RD, Sheffler DJ, Niswender CM, Daniels JS, Conn PJ, Lindsley CW, Wood MR.
Melancon BJ, et al. Among authors: mattmann me.
Bioorg Med Chem Lett. 2012 Aug 1;22(15):5035-40. doi: 10.1016/j.bmcl.2012.06.018. Epub 2012 Jun 15.
Bioorg Med Chem Lett. 2012.
PMID: 22749871
Free PMC article.